CLAUDINE BAE: Open Payments
NPI 1437687837 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 8 payments from 5 companies in 2025. Trend: 2023 $515 · 2024 $34 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $132 |
| Inspire Medical Systems, Inc. | 1 | $130 |
| Amarin Pharma, Inc. | 1 | $118 |
| ARGENX US, INC. | 1 | $90 |
| Merck Sharp & Dohme LLC | 4 | $89 |
Products named: INSPIRE, Vascepa, VYVGART, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
